GCM
ARA

Gladstone Capital Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

Gladstone Capital Management’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-122,005
Closed -$2.23M – 16
2016
Q3 		$2.23M Buy
122,005
+42,176
+53% +$951K 1.81% 9
2016
Q2 		$2.31M Buy
+79,829
New +$2.22M 2.18% 10

Other funds holding ARA

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Gladstone Capital Management's ARA Position: Q4 2016 in Review

Gladstone Capital Management sold out of American Renal Associates Holdings, Inc (ARA) in Q4 2016, closing a stake of 122,005 shares — an estimated $2.23M sold.

Gladstone Capital Management first reported a position in ARA in Q2 2016 and held it in 2 quarters. The position peaked at $2.31M in Q2 2016. 58 funds tracked by Wall St. Rank hold ARA as of Q4 2016.

  • Gladstone Capital Management reported no remaining American Renal Associates Holdings, Inc position as of Q4 2016 after selling out during the quarter.
  • Gladstone Capital Management sold 122,005 American Renal Associates Holdings, Inc shares in Q4 2016, an estimated $2.23M.
  • Gladstone Capital Management first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 2 quarters.
  • Gladstone Capital Management's American Renal Associates Holdings, Inc position peaked at $2.31M in Q2 2016.
  • 58 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q4 2016.

Based on Gladstone Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.